Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone and Physiotherapy for Chronic Subacromial Bursitis
NCT03871465Completed
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Aug 2018
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of triamcinolone in subacromial bursitis (3 arms), sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Primary endpoints: Visual Analog Scale at 8 weeks and Shoulder Pain and Disability Index at 8 weeks. Started Aug 2018; status: completed.
02
Drugs
triamcinolone
03
Conditions
subacromial bursitis
Beyond the preview
Go deeper on NCT03871465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03871465.